- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Radiopharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Radiopharmaceutical market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 8281 million by 2025, from USD 6035.2 million in 2019.
Market segmentation
Radiopharmaceutical market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Radiopharmaceutical market has been segmented into Actinium-225, Lutetium-177, Radium-223, Holmium-166, Other, etc.
Breakdown by Application, Radiopharmaceutical has been segmented into Oncology, Cardiology, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Radiopharmaceutical market presented in the report. This section sheds light on the sales growth of different regional and country-level Radiopharmaceutical markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Radiopharmaceutical market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Radiopharmaceutical Market Share Analysis
Radiopharmaceutical competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Radiopharmaceutical sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Radiopharmaceutical sales, revenue and market share for each player covered in this report.
The major players covered in Radiopharmaceutical are: Bracco Imaging, GE Healthcare, Nordion, Bayer, IBA Group, Mallinckrodt, Jubilant Pharma, Lantheus, Triad Isotopes, China Isotope & Radiation, Navidea, Eli Lilly, Dongcheng, Advanced Accelerator Applications, SIEMENS, etc. Among other players domestic and global, Radiopharmaceutical market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Radiopharmaceutical market are listed below:
Bracco Imaging
GE Healthcare
Nordion
Bayer
IBA Group
Mallinckrodt
Jubilant Pharma
Lantheus
Triad Isotopes
China Isotope & Radiation
Navidea
Eli Lilly
Dongcheng
Advanced Accelerator Applications
SIEMENS
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Market segment by Application, can be divided into
Oncology
Cardiology
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Radiopharmaceutical Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Radiopharmaceutical Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size and Forecast (2015-2025)
1.4.1 Global Radiopharmaceutical Revenue and Forecast (2015-2025)
1.4.2 Global Radiopharmaceutical Sales and Forecast (2015-2025)
1.5 Global Radiopharmaceutical Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging SWOT Analysis
2.1.4 Bracco Imaging Product and Services
2.1.5 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare SWOT Analysis
2.2.4 GE Healthcare Product and Services
2.2.5 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Nordion
2.3.1 Nordion Details
2.3.2 Nordion Major Business
2.3.3 Nordion SWOT Analysis
2.3.4 Nordion Product and Services
2.3.5 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 IBA Group
2.5.1 IBA Group Details
2.5.2 IBA Group Major Business
2.5.3 IBA Group SWOT Analysis
2.5.4 IBA Group Product and Services
2.5.5 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mallinckrodt
2.6.1 Mallinckrodt Details
2.6.2 Mallinckrodt Major Business
2.6.3 Mallinckrodt Product and Services
2.6.4 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Jubilant Pharma
2.7.1 Jubilant Pharma Details
2.7.2 Jubilant Pharma Major Business
2.7.3 Jubilant Pharma Product and Services
2.7.4 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Product and Services
2.8.4 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Triad Isotopes
2.9.1 Triad Isotopes Details
2.9.2 Triad Isotopes Major Business
2.9.3 Triad Isotopes Product and Services
2.9.4 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 China Isotope & Radiation
2.10.1 China Isotope & Radiation Details
2.10.2 China Isotope & Radiation Major Business
2.10.3 China Isotope & Radiation Product and Services
2.10.4 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Navidea
2.11.1 Navidea Details
2.11.2 Navidea Major Business
2.11.3 Navidea Product and Services
2.11.4 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business
2.12.3 Eli Lilly Product and Services
2.12.4 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Dongcheng
2.13.1 Dongcheng Details
2.13.2 Dongcheng Major Business
2.13.3 Dongcheng Product and Services
2.13.4 Dongcheng Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Advanced Accelerator Applications
2.14.1 Advanced Accelerator Applications Details
2.14.2 Advanced Accelerator Applications Major Business
2.14.3 Advanced Accelerator Applications Product and Services
2.14.4 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 SIEMENS
2.15.1 SIEMENS Details
2.15.2 SIEMENS Major Business
2.15.3 SIEMENS Product and Services
2.15.4 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Radiopharmaceutical Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Radiopharmaceutical Sales in United States (2018-2019)
3.2.2 United States Radiopharmaceutical Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceutical Manufacturer Market Share in 2019
3.3.2 Top 6 Radiopharmaceutical Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Radiopharmaceutical Market Size by Geography (2015-2020)
4.1.1 Global Radiopharmaceutical Sales by Geography (2015-2020)
4.1.2 Global Radiopharmaceutical Revenue by Regions (2015-2020)
4.2 Global Radiopharmaceutical Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Radiopharmaceutical Sales and Forecast by Regions (2020-2025)
4.2.2 Global Radiopharmaceutical Revenue and Forecast by Regions (2020-2025)
4.3 North America Radiopharmaceutical Market Size and Forecast (2015-2025)
4.4 Europe Radiopharmaceutical Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Radiopharmaceutical Market Size and Forecast (2015-2025)
4.6 South America Radiopharmaceutical Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Radiopharmaceutical Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Radiopharmaceutical Market Size by Country (2015-2020)
5.1.1 North America Radiopharmaceutical Sales and Market Share by Country (2015-2020)
5.1.2 North America Radiopharmaceutical Revenue and Market Share by Country (2015-2020)
5.2 North America Radiopharmaceutical Market Size and Forecast by Country (2020-2025)
5.2.1 North America Radiopharmaceutical Sales and Forecast by Country (2020-2025)
5.2.2 North America Radiopharmaceutical Revenue and Forecast by Country (2020-2025)
5.3 United States Radiopharmaceutical Market Size and Forecast (2015-2025)
5.4 Canada Radiopharmaceutical Market Size and Forecast (2015-2025)
5.5 Mexico Radiopharmaceutical Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Radiopharmaceutical Market Size by Country (2015-2020)
6.1.1 Europe Radiopharmaceutical Sales by Country (2015-2020)
6.1.2 Europe Radiopharmaceutical Revenue by Country (2015-2020)
6.2 Europe Radiopharmaceutical Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Radiopharmaceutical Sales and Forecast by Country (2020-2025)
6.2.2 Europe Radiopharmaceutical Revenue and Forecast by Country (2020-2025)
6.3 Germany Radiopharmaceutical Market Size and Forecast (2015-2025)
6.4 United Kingdom Radiopharmaceutical Market Size and Forecast (2015-2025)
6.5 France Radiopharmaceutical Market Size and Forecast (2015-2025)
6.6 Russia Radiopharmaceutical Market Size and Forecast (2015-2025)
6.7 Italy Radiopharmaceutical Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Radiopharmaceutical Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Radiopharmaceutical Sales by Region (2015-2020)
7.1.2 Asia-Pacific Radiopharmaceutical Revenue by Region (2015-2020)
7.2 Asia-Pacific Radiopharmaceutical Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Radiopharmaceutical Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Radiopharmaceutical Revenue and Forecast by Region (2020-2025)
7.3 China Radiopharmaceutical Market Size and Forecast (2015-2025)
7.4 Japan Radiopharmaceutical Market Size and Forecast (2015-2025)
7.5 Korea Radiopharmaceutical Market Size and Forecast (2015-2025)
7.6 India Radiopharmaceutical Market Size and Forecast (2015-2025)
7.7 Southeast Asia Radiopharmaceutical Market Size and Forecast (2015-2025)
7.8 Australia Radiopharmaceutical Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Radiopharmaceutical Market Size by Country (2015-2020)
8.1.1 South America Radiopharmaceutical Sales by Country (2015-2020)
8.1.2 South America Radiopharmaceutical Revenue by Country (2015-2020)
8.2 South America Radiopharmaceutical Market Size and Forecast by Country (2020-2025)
8.2.1 South America Radiopharmaceutical Sales and Forecast by Country (2020-2025)
8.2.2 South America Radiopharmaceutical Revenue and Forecast by Country (2020-2025)
8.3 Brazil Radiopharmaceutical Market Size and Forecast (2015-2025)
8.4 Argentina Radiopharmaceutical Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Radiopharmaceutical Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Radiopharmaceutical Sales by Country (2015-2020)
9.1.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2015-2020)
9.2 Middle East & Africa Radiopharmaceutical Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Radiopharmaceutical Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Radiopharmaceutical Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Radiopharmaceutical Market Size and Forecast (2015-2025)
9.4 Turkey Radiopharmaceutical Market Size and Forecast (2015-2025)
9.5 Egypt Radiopharmaceutical Market Size and Forecast (2015-2025)
9.6 South Africa Radiopharmaceutical Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Radiopharmaceutical Market Size by Type (2015-2020)
10.1.1 Global Radiopharmaceutical Sales by Type (2015-2020)
10.1.2 Global Radiopharmaceutical Revenue by Type (2015-2020)
10.1.3 Global Radiopharmaceutical Price by Type (2015-2020)
10.2 Global Radiopharmaceutical Market Size and Forecast by Type (2020-2025)
10.2.1 Global Radiopharmaceutical Sales and Forecast by Type (2020-2025)
10.2.2 Global Radiopharmaceutical Revenue and Forecast by Type (2020-2025)
10.2.3 Global Radiopharmaceutical Price and Forecast by Type (2020-2025)
10.3 United States Radiopharmaceutical Market Size and Forecast by Type (2015-2025)
10.3.1 United States Radiopharmaceutical Market Size by Type (2015-2020)
10.3.2 United States Radiopharmaceutical Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Radiopharmaceutical Market Size by Application (2015-2020)
11.1.1 Global Radiopharmaceutical Sales by Application (2015-2020)
11.1.2 Global Radiopharmaceutical Revenue by Application (2015-2020)
11.1.3 Global Radiopharmaceutical Price by Application (2015-2020)
11.2 Global Radiopharmaceutical Market Size and Forecast by Application (2020-2025)
11.2.1 Global Radiopharmaceutical Sales and Forecast by Application (2020-2025)
11.2.2 Global Radiopharmaceutical Revenue and Forecast by Application (2020-2025)
11.2.3 Global Radiopharmaceutical Price and Forecast by Application (2020-2025)
11.3 United States Radiopharmaceutical Market Size and Forecast by Application (2015-2025)
11.3.1 United States Radiopharmaceutical Market Size by Application (2015-2020)
11.3.2 United States Radiopharmaceutical Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Radiopharmaceutical Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Radiopharmaceutical Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Radiopharmaceutical Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Global Radiopharmaceutical Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 7. Bracco Imaging Radiopharmaceutical Major Business
Table 8. Bracco Imaging Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 9. Bracco Imaging SWOT Analysis
Table 10. Bracco Imaging Radiopharmaceutical Product and Services
Table 11. Bracco Imaging Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 12. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 13. GE Healthcare Radiopharmaceutical Major Business
Table 14. GE Healthcare Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 15. GE Healthcare SWOT Analysis
Table 16. GE Healthcare Radiopharmaceutical Product and Services
Table 17. GE Healthcare Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 18. Nordion Basic Information, Manufacturing Base and Competitors
Table 19. Nordion Radiopharmaceutical Major Business
Table 20. Nordion Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 21. Nordion SWOT Analysis
Table 22. Nordion Radiopharmaceutical Product and Services
Table 23. Nordion Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 24. Bayer Basic Information, Manufacturing Base and Competitors
Table 25. Bayer Radiopharmaceutical Major Business
Table 26. Bayer Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 27. Bayer SWOT Analysis
Table 28. Bayer Radiopharmaceutical Product and Services
Table 29. Bayer Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 30. IBA Group Basic Information, Manufacturing Base and Competitors
Table 31. IBA Group Radiopharmaceutical Major Business
Table 32. IBA Group Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 33. IBA Group SWOT Analysis
Table 34. IBA Group Radiopharmaceutical Product and Services
Table 35. IBA Group Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 36. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 37. Mallinckrodt Radiopharmaceutical Major Business
Table 38. Mallinckrodt Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 39. Mallinckrodt SWOT Analysis
Table 40. Mallinckrodt Radiopharmaceutical Product and Services
Table 41. Mallinckrodt Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 42. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 43. Jubilant Pharma Radiopharmaceutical Major Business
Table 44. Jubilant Pharma Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 45. Jubilant Pharma SWOT Analysis
Table 46. Jubilant Pharma Radiopharmaceutical Product and Services
Table 47. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 48. Lantheus Basic Information, Manufacturing Base and Competitors
Table 49. Lantheus Radiopharmaceutical Major Business
Table 50. Lantheus Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 51. Lantheus SWOT Analysis
Table 52. Lantheus Radiopharmaceutical Product and Services
Table 53. Lantheus Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 54. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 55. Triad Isotopes Radiopharmaceutical Major Business
Table 56. Triad Isotopes Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 57. Triad Isotopes SWOT Analysis
Table 58. Triad Isotopes Radiopharmaceutical Product and Services
Table 59. Triad Isotopes Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 60. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 61. China Isotope & Radiation Radiopharmaceutical Major Business
Table 62. China Isotope & Radiation Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 63. China Isotope & Radiation SWOT Analysis
Table 64. China Isotope & Radiation Radiopharmaceutical Product and Services
Table 65. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 66. Navidea Basic Information, Manufacturing Base and Competitors
Table 67. Navidea Radiopharmaceutical Major Business
Table 68. Navidea Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 69. Navidea SWOT Analysis
Table 70. Navidea Radiopharmaceutical Product and Services
Table 71. Navidea Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 72. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 73. Eli Lilly Radiopharmaceutical Major Business
Table 74. Eli Lilly Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 75. Eli Lilly SWOT Analysis
Table 76. Eli Lilly Radiopharmaceutical Product and Services
Table 77. Eli Lilly Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 78. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 79. Dongcheng Radiopharmaceutical Major Business
Table 80. Dongcheng Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 81. Dongcheng SWOT Analysis
Table 82. Dongcheng Radiopharmaceutical Product and Services
Table 83. Dongcheng Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 84. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 85. Advanced Accelerator Applications Radiopharmaceutical Major Business
Table 86. Advanced Accelerator Applications Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 87. Advanced Accelerator Applications SWOT Analysis
Table 88. Advanced Accelerator Applications Radiopharmaceutical Product and Services
Table 89. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 90. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 91. SIEMENS Radiopharmaceutical Major Business
Table 92. SIEMENS Radiopharmaceutical Total Revenue (USD Million) (2018-2019)
Table 93. SIEMENS SWOT Analysis
Table 94. SIEMENS Radiopharmaceutical Product and Services
Table 95. SIEMENS Radiopharmaceutical Sales (M Doses), Price (USD/Dose), Revenue, Gross Margin and Market Share (2018-2019)
Table 96. Global Radiopharmaceutical Sales by Manufacturer (2018-2019) (M Doses)
Table 97. Global Radiopharmaceutical Revenue by Manufacturer (2018-2019) (USD Million)
Table 98. Key Players Radiopharmaceutical Sales in United States (2018-2019) (M Doses)
Table 99. Key Players Radiopharmaceutical Sales Market Share in United States (2018-2019)
Table 100. Key Players Revenue of Radiopharmaceutical in United States (2018-2019) (USD Million)
Table 101. Global Radiopharmaceutical Sales by Regions (2015-2020) (M Doses)
Table 102. Global Radiopharmaceutical Sales Market Share by Regions (2015-2020)
Table 103. Global Radiopharmaceutical Revenue by Regions (2015-2020) (USD Million)
Table 104. Global Radiopharmaceutical Sales and Forecast by Regions (2020-2025) (M Doses)
Table 105. Global Radiopharmaceutical Sales Market Share by Regions (2020-2025)
Table 106. Global Radiopharmaceutical Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 107. Global Radiopharmaceutical Revenue Market Share by Regions (2020-2025) (USD Million)
Table 108. North America Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 109. North America Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 110. North America Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 111. North America Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 112. North America Radiopharmaceutical Sales by Country (2020-2025) (M Doses)
Table 113. North America Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 114. North America Radiopharmaceutical Revenue by Country (2020-2025) (USD Million)
Table 115. North America Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 116. Europe Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 117. Europe Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 118. Europe Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 119. Europe Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 120. Europe Radiopharmaceutical Sales by Country (2020-2025) (M Doses)
Table 121. Europe Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 122. Europe Radiopharmaceutical Revenue by Country (2020-2025) (USD Million)
Table 123. Europe Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 124. Asia-Pacific Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 125. Asia-Pacific Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 126. Asia-Pacific Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 127. Asia-Pacific Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 128. Asia-Pacific Radiopharmaceutical Sales by Country (2020-2025) (M Doses)
Table 129. Asia-Pacific Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 130. Asia-Pacific Radiopharmaceutical Revenue by Country (2020-2025) (USD Million)
Table 131. Asia-Pacific Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 132. South America Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 133. South America Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 134. South America Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 135. South America Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 136. South America Radiopharmaceutical Sales by Country (2020-2025) (M Doses)
Table 137. South America Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 138. South America Radiopharmaceutical Revenue by Country (2020-2025) (USD Million)
Table 139. South America Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 140. Middle East & Africa Radiopharmaceutical Sales by Countries (2015-2020) (M Doses)
Table 141. Middle East & Africa Radiopharmaceutical Sales Market Share by Countries (2015-2020)
Table 142. Middle East & Africa Radiopharmaceutical Revenue by Countries (2015-2020) (USD Million)
Table 143. Middle East & Africa Radiopharmaceutical Revenue Market Share by Countries (2015-2020)
Table 144. Middle East & Africa Radiopharmaceutical Sales by Country (2020-2025) (M Doses)
Table 145. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2020-2025)
Table 146. Middle East & Africa Radiopharmaceutical Revenue by Country (2020-2025) (USD Million)
Table 147. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2020-2025)
Table 148. United States Radiopharmaceutical Sales by Type (2015-2020) (M Doses)
Table 149. United States Radiopharmaceutical Sales Market Share by Type (2015-2020)
Table 150. United States Radiopharmaceutical Revenue by Type (2015-2020) (USD Million)
Table 151. United States Radiopharmaceutical Revenue Market Share by Type (2015-2020)
Table 152. United States Radiopharmaceutical Sales by Type (2020-2025) (M Doses)
Table 153. United States Radiopharmaceutical Sales Market Share by Type (2020-2025)
Table 154. United States Radiopharmaceutical Revenue by Type (2020-2025) (USD Million)
Table 155. United States Radiopharmaceutical Revenue Market Share by Type (2020-2025)
Table 156. Global Radiopharmaceutical Sales by Application (2015-2020) (M Doses)
Table 157. Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 158. Global Radiopharmaceutical Revenue by Application (2015-2020) (USD Million)
Table 159. Global Radiopharmaceutical Revenue Market Share by Application (2015-2020)
Table 160. Global Radiopharmaceutical Price by Application (2015-2020) (USD/Dose)
Table 161. Global Radiopharmaceutical Sales by Application (2020-2025) (M Doses)
Table 162. Global Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 163. Global Radiopharmaceutical Revenue by Application (2020-2025) (USD Million)
Table 164. Global Radiopharmaceutical Revenue Market Share by Application (2020-2025)
Table 165. Global Radiopharmaceutical Price by Application (2020-2025) (USD/Dose)
Table 166. United States Radiopharmaceutical Sales by Application (2015-2020) (M Doses)
Table 167. United States Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 168. United States Radiopharmaceutical Revenue by Application (2015-2020) (USD Million)
Table 169. United States Radiopharmaceutical Revenue Market Share by Application (2015-2020)
Table 170. United States Radiopharmaceutical Sales by Application (2020-2025) (M Doses)
Table 171. United States Radiopharmaceutical Sales Market Share by Application (2020-2025)
Table 172. United States Radiopharmaceutical Revenue by Application (2020-2025) (USD Million)
Table 173. United States Radiopharmaceutical Revenue Market Share by Application (2020-2025)
Table 174. Direct Channel Pros & Cons
Table 175. Indirect Channel Pros & Cons
Table 176. Distributors/Traders/ Dealers List
Table 177. Customers of Radiopharmaceutical
Table 178. Market Opportunities in Next Few Years
Table 179. Market Risks Analysis
Table 180. Market Drivers
List of Figures
Figure 1. Radiopharmaceutical Picture
Figure 2. Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Actinium-225 Picture
Figure 4. Lutetium-177 Picture
Figure 5. Radium-223 Picture
Figure 6. Holmium-166 Picture
Figure 7. Other Picture
Figure 8. Radiopharmaceutical Sales Market Share by Application in 2019
Figure 9. Oncology Picture
Figure 10. Cardiology Picture
Figure 11. Other Picture
Figure 12. Global Radiopharmaceutical Market Status and Outlook (2015-2025) (USD Million)
Figure 13. Global Radiopharmaceutical Sales Growth Rate (2015-2025) (M Doses)
Figure 14. Global Radiopharmaceutical Sales Market Share by Manufacturer in 2019
Figure 15. Global Radiopharmaceutical Revenue Market Share by Manufacturer in 2019
Figure 16. Key Players Radiopharmaceutical Revenue Market Share in United States in 2019
Figure 17. Global Top 5 Radiopharmaceutical Manufacturer Market Share in 2019
Figure 18. Top 3 Radiopharmaceutical Players Market Share in United States in 2019
Figure 19. Global Radiopharmaceutical Revenue Market Share by Regions in 2019
Figure 20. North America Radiopharmaceutical Sales YoY Growth (2015-2025) (M Doses)
Figure 21. North America Radiopharmaceutical Revenue YoY Growth (2015-2025) (USD Million)
Figure 22. Europe Radiopharmaceutical Sales YoY Growth (2015-2020) (M Doses)
Figure 23. Europe Radiopharmaceutical Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Asia-Pacific Radiopharmaceutical Sales YoY Growth (2015-2020) (M Doses)
Figure 25. Asia-Pacific Radiopharmaceutical Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. South America Radiopharmaceutical Sales YoY Growth (2015-2020) (M Doses)
Figure 27. South America Radiopharmaceutical Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Middle East & Africa Radiopharmaceutical Sales YoY Growth (2015-2020) (M Doses)
Figure 29. Middle East & Africa Radiopharmaceutical Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. North America Radiopharmaceutical Sales Market Share by Country in 2019
Figure 31. North America Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 32. United States Radiopharmaceutical Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Canada Radiopharmaceutical Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Mexico Radiopharmaceutical Market Size and Growth Rate (2015-2020) (USD Million)
Figure 35. Europe Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 36. Germany Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. United Kingdom Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. France Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Russia Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Italy Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Asia-Pacific Radiopharmaceutical Sales Market Share by Region 2018
Figure 42. Asia-Pacific Radiopharmaceutical Revenue Market Share by Region 2018
Figure 43. China Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Japan Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Korea Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. India Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Southeast Asia Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Australia Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. South America Radiopharmaceutical Sales Market Share by Country in 2019
Figure 50. South America Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 51. Brazil Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Argentina Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Saudi Arabia Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Turkey Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Egypt Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. South Africa Radiopharmaceutical Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Global Revenue Market Share of Radiopharmaceutical by Type in 2019
Figure 58. Global Revenue Market Share of Radiopharmaceutical by Application in 2019
Figure 59. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
